Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00932_DB01357_nanopub.RAc9aTdVbLDuan2Yc8_UdDBHo0qouOfDPk6er4MoAl_dM#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00932_DB01357 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00932_DB01357 label "DDI between Tipranavir and Mestranol - Mestranol may increase the adverse dermatological effects (i.e. skin rash) of Tipranavir. Tipranavir may decrease the serum concentration Mestranol. Use an alternate form of contraception or monitor for estrogen deficiency if Mestranol is used for hormone replacement therapy. [drugbank_resource:DB00932_DB01357]" assertion.
- drugbank_resource:DB00932_DB01357 identifier "drugbank_resource:DB00932_DB01357" assertion.
- drugbank_resource:DB00932_DB01357 title "DDI between Tipranavir and Mestranol - Mestranol may increase the adverse dermatological effects (i.e. skin rash) of Tipranavir. Tipranavir may decrease the serum concentration Mestranol. Use an alternate form of contraception or monitor for estrogen deficiency if Mestranol is used for hormone replacement therapy." assertion.
- drugbank:DB01357 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00932_DB01357 assertion.
- drugbank:DB00932 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00932_DB01357 assertion.